Balyasny Asset Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-693	Closed	-$11.5K	–	2445
2024 Q2	$11.5K	Buy	+693	New	+$11.5K	﹤0.01%	1851
2023 Q1	–	Sell	-1,474	Closed	-$174K	–	2722
2022 Q4	$174K	Buy	+1,474	New	+$174K	﹤0.01%	1721